Cargando…

Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients

Resistance to recombinant erythropoietin (rEPO) in hemodialysis patients may be due to inadequate iron recruitment and defect in iron use. In this cross over randomized clinical trial, 30 hemodialysis patients with serum ferritin levels of ≥500 ng/ml, hemoglobin ≤11.0 g/dl, and transferrin saturatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jalalzadeh, M., Shekari, E., Mirzamohammadi, F., Ghadiani, M. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459518/ https://www.ncbi.nlm.nih.gov/pubmed/23087549 http://dx.doi.org/10.4103/0971-4065.86407

Ejemplares similares

Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients
por: Ghadiani, Mohammad H., et al.
Publicado: (2012)

The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
por: Kang, Dae Woong, et al.
Publicado: (2012)

Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in Hemodialysis Patients
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Role of Intravenous Ascorbic Acid in the Management of Anemia in Hemodialysis Patients
por: El Shinnawy, Howayda, et al.
Publicado: (2021)

Association Between Metabolic Syndrome and Coronary Heart Disease in Patients on Hemodialysis
por: Jalalzadeh, Mojgan, et al.
Publicado: (2015)

The Impact of Acute Rejection in Kidney Transplantation on Long-Term Allograft and Patient Outcome
por: Jalalzadeh, Mojgan, et al.
Publicado: (2015)

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
por: Wagner, Samuel C, et al.
Publicado: (2014)

Reduced Plasma Ascorbate and Increased Proportion of Dehydroascorbic Acid Levels in Patients Undergoing Hemodialysis
por: Doshida, Yuta, et al.
Publicado: (2021)

Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial
por: Sedighi, Omid, et al.
Publicado: (2013)

Administration of Intravenous Ascorbic Acid—Practical Considerations for Clinicians
por: Walker, Scott E., et al.
Publicado: (2019)

Delphinidin immobilized on silver nanoparticles for the simultaneous determination of ascorbic acid, noradrenalin, uric acid, and tryptophan
por: Nasirizadeh, Navid, et al.
Publicado: (2016)

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
por: Ichim, Thomas E, et al.
Publicado: (2011)

Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients
por: Kshirsagar, Abhijit V., et al.
Publicado: (2013)

A Case of Factitious Hyperglycemia in a Patient on Intravenous Ascorbic Acid
por: Sharma, Eliza, et al.
Publicado: (2018)

Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer
por: Bazzan, Anthony J., et al.
Publicado: (2018)

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
por: Fowler, Alpha A, et al.
Publicado: (2014)

High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
por: Honda, Hirokazu, et al.
Publicado: (2017)

Intravenous Ascorbic Acid and Lung Function in Severely Ill COVID-19 Patients
por: Sokary, Sara, et al.
Publicado: (2022)

Membrane Permeabilities of Ascorbic Acid and Ascorbate
por: Hannesschlaeger, Christof, et al.
Publicado: (2018)

Ascorbic acid serum levels are reduced in patients with hematological malignancies
por: Huijskens, Mirelle J.A.J., et al.
Publicado: (2016)

Prolonged Altered Mental Status in a Diabetic Hemodialysis Patient
por: Jalalzadeh, Mojgan, et al.
Publicado: (2021)

Correction: High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
Publicado: (2017)

Blood Transfusion, Serum Ferritin, and Iron in Hemodialysis Patients in Africa
por: Kouegnigan Rerambiah, Leonard, et al.
Publicado: (2015)

Could ferritin help the screening for COVID-19 in hemodialysis patients?
por: Bataille, Stanislas, et al.
Publicado: (2020)

Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate Therapy
por: Mikirova, Nina, et al.
Publicado: (2016)

Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
por: Nauman, Gina, et al.
Publicado: (2018)

Observations of Ascorbic Acid. Part XI. Therapeutic Effect of Ascorbic Acid in Tuberculosis
por: Babbar, Inder Jit
Publicado: (1948)

Role of very short-term intravenous hydrocortisone in reducing postdural puncture headache
por: Alam, Md Rabiul, et al.
Publicado: (2012)

Efficiency of long-term high-dose intravenous ascorbic acid therapy in locally advanced basal cell carcinoma – a pilot study
por: Bánvölgyi, András, et al.
Publicado: (2019)

Pharmacokinetics of intravenous administered two different high doses of ascorbic acid in healthy beagle dogs
por: Lim, Seula, et al.
Publicado: (2019)

Salmonella Typhimurium Infection Reduces the Ascorbic Acid Uptake in the Intestine
por: Teafatiller, Trevor, et al.
Publicado: (2023)

Stability of aqueous solutions of ascorbate for basic research and for intravenous administration
por: Wagner, Brett A., et al.
Publicado: (2023)

ON THE INACTIVATION OF ASCORBIC ACID OXIDASE
por: Powers, Wendell H., et al.
Publicado: (1944)

Consequences of Interdialytic Weight Gain Among Hemodialysis Patients
por: Jalalzadeh, Mojgan, et al.
Publicado: (2021)

Multisystem Inflammatory Syndrome in an Adult on Hemodialysis with Markedly Elevated Procalcitonin and Ferritin Levels
por: Asano, Shuichi, et al.
Publicado: (2023)

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
por: Monti, Daniel A., et al.
Publicado: (2012)

A randomized feasibility study of the effect of ascorbic acid on post-angioplasty restenosis of hemodialysis vascular access (NCT03524846)
por: Yang, Chung-Wei, et al.
Publicado: (2019)

Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients
por: Takasawa, Kazuya, et al.
Publicado: (2014)

Correlation Between C-reactive Protein and Non-enzymatic Antioxidants (Albumin, Ferritin, Uric Acid and Bilirubin) in Hemodialysis Patients
por: Beciragic, Amela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ldo2spjom9vtmj4qj1l3ilt866